Flare Capital

What is Flare Capital?

Flare Capital Partners is a prominent investment firm specializing in the healthcare technology sector. With a focus on transforming healthcare, they are dedicated to collaborating with entrepreneurs to enhance health outcomes and reduce costs. The firm is recognized for being one of the largest investors in the space, signifying a substantial commitment to their investment thesis.

They take pride in their comprehensive portfolio, featuring entrepreneurs who address critical issues throughout the healthcare industry, ranging from the improvement of day-to-day clinical operations to revolutionizing patient care and health management systems. A defining characteristic of Flare Capital is the way they leverage strategic relationships; their strategic limited partners not only contribute financially but also provide early market access as customers, distribution channels, and co-investors. They highlight these partnerships by showcasing their reach, which extends to 99.1 million insured lives, generating $1.2 trillion in annual revenue, and influencing a significant portion of healthcare IT spend.

Flare Capital's local presence spans over 181 countries, 506 hospitals, 22.9k retail locations, 113.6 million outpatient visits, and 655 million annual lab samples, indicating a deep penetration into the healthcare market. The firm regularly shares insights and predictions for the healthcare sector, emphasizing their thought leadership and investment foresight.

These insights cover a variety of topics, including long-term healthcare trends, the intersection of AI and healthcare, and analyses of healthcare funding over time. Flare Capital's dedication to the industry is further emphasized by their active communication platforms, where they offer news on their entrepreneurs and portfolio companies, and provide expert perspectives on the evolving healthcare landscape.

What they say:

We are committed to nurturing nascent and growing businesses in the health sector.

What we look for: We invest in early-stage and emerging healthtech companies.